• -
  • English
  • Japanese
  • Korean
表紙
市場調查報告書
商品編碼
737889

非口服營養的全球市場:分析，佔有率，趨勢，規模，預測

Parenteral Nutrition Market, By Nutrient Type (Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Single Dose Amino Acid Solution, and Vitamins & Minerals) and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日期: | 出版商: AnalystView Market Insights | 英文 143 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球非口服營養市場調查分析，提供市場概要，市場趨勢，產業分析，市場形勢，各市場區隔的市場分析，主要供應商分析相關的系統性資訊。

第1章 非口服營養:市場概要

  • 調查範圍
  • 前提條件與調查手法

第2章 摘要整理

第3章 非口服營養:主要的市場趨勢

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場未來趨勢

第4章 非口服營養:產業分析

  • 波特的五力分析
  • 市場魅力分析
  • 法律規範分析

第5章 非口服營養:市場形勢

  • 市場佔有率分析

第6章 非口服營養市場:營養類別

  • 概要
  • 非口服脂肪乳劑
  • 碳水化合物
  • 微量礦物質
  • 單劑量氨基酸溶液
  • 維生素和礦物質

第7章 非口服營養市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 主要供應商分析

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Allergan Plc

第9章 分析師的見解

第10章 附錄

目錄
Product Code: AV200

Report Hightlights

The parenteral nutrition market is estimated to represent a global market of USD 4.93 billion by 2017 with growth rate of 6.1%.

Market Dynamics

Parenteral nutrition (also termed as Total Parenteral Nutrition) is a sterile solution that contains macronutrient (i.e. lipid, carbohydrate etc.) and micronutrient (minerals, vitamins etc.). The solution is directly infused into the bloodstream through an intravenous infusion pump, bypassing the digestive system. Special types of intravenous catheters such as Broviac, Hickman, and triple or double lumen catheters are used for this purpose. The growth of this industry is majorly attributed to the rising number of malnutrition cases across the globe. According to the Global Alliance for Improved Nutrition, more than two billion people suffer from a different form of malnutrition worldwide. As per the organization, globally, more than 2.6 million children die due to the lack of proper nutrition every year.

Parenteral nutrition enables an individual in achieving proper nutritional intake in a timely manner. Thereby, the demand for nutrient uptake through the parenteral route is increasing with the rising number of people with malnutrition, driving the industry growth. Other factors such as an aging population coupled with rising prevalence of chronic medical conditions spur the growth of this industry over the forecast period. On the contrary, potential complications associated with parenteral nutrition such as Intravenous access-related trauma, Air embolus, and Thrombophlebitis hampers the market growth to some extent.

Nutrient Type Takeaway

In terms of nutrient type, the market is categorized as Parenteral Lipid Emulsion, Carbohydrates, Trace elements, Single Dose Amino Acid Solution, and Vitamins & Minerals. Single dose amino acid solution accounted for the highest share. In 2017, the segment recorded USD 1.5 billion and is projected to dominate the industry over the study period. Developing regions such as the Asia Pacific and Latin America are the target market for single dose amino acid solutions owing to the rising incidences of protein deficiency diseases such as Kwashiorkor and Marasmus. Nirmin (Nirlife Pharma) and Aminosyn (Hospira, Inc.) are some of the commercially available products under this segment. However, parenteral lipid emulsions and carbohydrates are anticipated to grow with a lucrative growth rate over the study period.

Global Parenteral Nutrition Market, by Nutrient Type, 2017 vs 2025

Regional Takeaway

Region wise, North America and Europe accounted for more than 75% revenue share collectively in 2017. Aggressive strategies adopted by leading players to expand their presence in these regions act as a potential driver for industry growth. For instance, in August 2017, Baxter collaborated with the American Society for Parenteral and Enteral Nutrition (ASPEN) which aims to increase awareness regarding the appropriate use of nutritional therapy.

The initiation is named as "SmartPN" that provides healthcare professionals with educational tools on the proper use of PN therapy that helps in reducing malnutrition cases and achieve better health outcomes. Asia Pacific accounted for over 14% revenue share in 2017 and is projected to grow with 6.9% CAGR over the study period. Growing geriatric population, rising demand for home healthcare coupled with increasing prevalence of chronic diseases support the regional growth.

Key Vendor Takeaway

Key players such as Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., and Allergan Plc are operating in this market. These key players are actively involved in improving the current portfolio of parenteral nutrition in order to sustain their position in the market. For example, Baxter offers one of the broadest portfolios under parenteral nutrition segment, which includes vitamins and lipids, premix IV solutions, as well as labelling, pharmacy workflow management, and compounding technology. Additionally, the company received marketing authorization for its product NUMETA G13E from the competent authorities in the Denmark and U.K.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY NUTRIENT TYPE

Parenteral Lipid Emulsion

Carbohydrates

Trace Elements

Single Dose Amino Acid Solution

Vitamins & Minerals

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. PARENTERAL NUTRITION MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. PARENTERAL NUTRITION KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. PARENTERAL NUTRITION INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. PARENTERAL NUTRITION MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. PARENTERAL NUTRITION MARKET - BY NUTRIENT TYPE

  • 6.1. Overview
  • 6.2. Parenteral Lipid Emulsion
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Carbohydrates
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. Trace Elements
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.5. Single Dose Amino Acid Solution
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.6. Vitamins & Minerals
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. PARENTERAL NUTRITION MARKET- BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.2.3. U.S.
    • 7.2.3.1. Overview
    • 7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.2.4. Canada
    • 7.2.4.1. Overview
    • 7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Europe
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.3. France
    • 7.3.3.1. Overview
    • 7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.4. Germany
    • 7.3.4.1. Overview
    • 7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.5. Rest of Europe
    • 7.3.5.1. Overview
    • 7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.4. Asia Pacific (APAC)
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.3. China
    • 7.4.3.1. Overview
    • 7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.4. India
    • 7.4.4.1. Overview
    • 7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.5. Rest of APAC
    • 7.4.5.1. Overview
    • 7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.5. Rest of the World
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.5.3. Latin America
    • 7.5.3.1. Overview
    • 7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.5.4. Middle East and Africa
    • 7.5.4.1. Overview
    • 7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. KEY VENDOR ANALYSIS

  • 8.1. B. Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. SWOT Analysis
    • 8.1.3. Key Developments
  • 8.2. Fresenius Kabi AG
    • 8.2.1. Company Overview
    • 8.2.2. SWOT Analysis
    • 8.2.3. Key Developments
  • 8.3. Baxter International, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. SWOT Analysis
    • 8.3.3. Key Developments
  • 8.4. Pfizer, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. SWOT Analysis
    • 8.4.3. Key Developments
  • 8.5. Allergan Plc
    • 8.5.1. Company Overview
    • 8.5.2. SWOT Analysis
    • 8.5.3. Key Developments

Client can request additional company profiling as per specific requirements

9. 360 DEGREE ANALYSTVIEW

10. APPENDIX

  • 10.1. Research Methodology
  • 10.2. Abbreviations
  • 10.3. Disclaimer
  • 10.4. Contact Us

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Parenteral Nutrition Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10 Parenteral Nutrition Market, by Nutrient Type, 2014 - 2025 (USD Billion)
  • Table 11 Parenteral Nutrition Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 12 North America Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 13 U.S. Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 14 Canada Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 15 Europe Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 16 France Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 17 Germany Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 18 Asia Pacific Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 19 China Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 20 India Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 21 Latin America Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 22 MEA Parenteral Nutrition Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Parenteral Nutrition Market, by Nutrient Type, 2014 - 2025 (USD Billion)
  • Figure 6 Parenteral Nutrition Market, by Geography, 2014 - 2025 (USD Billion)